Four out of five patients with heterozygous GBA mutations exhibited early-onset parkinsonism, with a mean AAO of 41.20 ± 10.21 years and mean disease duration of 3.40 ± 2.30 years (Tables 1, 2). The gene discussed is GBA1; the disease is Parkinson disease.